Recent Finacing
Recent Raise
Courage Therapeutics is a pre-clinical biopharma developing melanocortin-targeted therapies for genetic and dietary obesity and diseases of wasting.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Courage Therapeutics.